-GAAPベースの売上高は3.5%増の65億ドル、営業利益率は130bps増の22.2%、EPSはすべて前年同期比38%減の1.55ドル

調整後売上高は63億ドル、既存事業売上高は前年同期比3.2%増

調整後営業利益率は24.7％、前年同期比170bpsの上昇

調整後EPSは前年同期比10％増の2.19ドル

-営業キャッシュフローは18億ドル、調整後フリー・キャッシュフローは13億ドル

-2025年調整後EPSガイダンスを7.75～8.00ドルから7.95～8.05ドルに引き上げ

セントポールミネソタ州ポール - 2025年10月21日 - 3M（NYSE: MMM）は本日、2025年度第3四半期の業績を発表した。

「3M会長兼CEOのウィリアム・ブラウンは、次のように述べています。「有機的なトップラインの成長を再活性化し、業務遂行能力を向上させることに注力した結果、当四半期も好調な業績を達成できたことを非常に喜ばしく思います。「3Mのエクセレンス・モデルは、既存事業の売上成長を加速し、利益率を高め、EPSを2桁成長させ、堅調なフリー・キャッシュ・フローを生み出すのに役立ちました。この進展により、通期の利益率とEPSのガイダンスを引き上げる自信がつきました。このガイダンスは、今年初めのインベスター・デイで発表した戦略的・財務的コミットメントを達成するのに有利なものです。

-GAAPベースのEPSは1.55ドル、営業利益率は22.2％。

-調整後EPSは前年同期比10％増の2.19ドル。

-調整後の営業利益率は24.7%で、前年同期比で170bp増加した。

-売上高は前年同期比3.5％増の65億ドル、既存事業売上高は同2.6％増。

-調整後売上高は前年同期比4.1％増の63億ドル、調整後既存事業売上高は同3.2％増。

-配当金と自社株買戻しにより9億ドルを株主に還元した。

-営業キャッシュは18億ドル。

-調整後フリー・キャッシュフローは13億ドル。

本書には特定の非GAAP基準の参照が含まれている。該当する情報については「補足財務情報 非GAAP指標」の項を参照されたい。

3M社は年初来の9ヶ月間の業績を踏まえ、2025年通年のガイダンスを更新した。

-調整後の総売上高成長率1 は2.5%超で、調整後の既存事業売上高成長率1 が2%超であったことを反映している。

-調整後営業利益率1は180bpsから200bpsの拡大。

-調整後EPS1は7.95～8.05ドル。

-調整後営業キャッシュフロー1は52億～54億ドルで、調整後フリーキャッシュフロー転換率1 は100%超に寄与。

1補足財務情報 非GAAP指標」の4でさらに説明したとおり、3Mは、比較可能な有意義なGAAP財務指標を作成するために必要な特定の項目を、不合理な努力なしに予測することができないため、これらの項目を反映した将来予測に基づく財務指標を提供していません。

3M社は本日午前9時（米国東部時間、日本時間午前8時）に投資家向け電話会議を開催する。投資家の皆様は以下からアクセスできます：

-ライブ・ウェブキャスト：https://investors.3M.com

ウェブキャスト再生：https://investors.3m.com/financials/quarterly-earnings

This document contains forward-looking statements. You can identify these statements by the use of words such as “plan,” “expect,” “aim,” “believe,” “project,” “target,” “anticipate,” “intend,” “estimate,” “will,” “should,” “could,” “would,” “forecast,” “future,” “outlook,” “guidance” and other words and terms of similar meaning. Forward-looking statements are based on certain assumptions and expectations of future events and trends that are subject to risks and uncertainties. Actual future results and trends may differ materially from historical results or those reflected in any such forward-looking statements depending on a variety of factors. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, regulatory, international trade, geopolitical, capital markets and other external conditions and other factors beyond the Company's control, including inflation; recession; military conflicts; trade restrictions such as sanctions, tariffs, reciprocal and retaliatory tariffs, and other tariff-related measures; regulatory requirements, legal actions, or enforcement; and natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) foreign currency exchange rates and fluctuations in those rates; (3) liabilities and the outcome of contingencies related to certain fluorochemicals; known as “PFAS,” including liabilities related to claims, lawsuits, and government regulatory proceedings concerning various PFAS-related products and chemistries, as well as risks related to the Company’s plans to exit PFAS manufacturing and work to discontinue use of PFAS across its product portfolio; (4) risks related to the class-action settlement (“PWS Settlement”) to resolve claims by public water suppliers in the United States regarding PFAS, as well as risks related to other settlements related to PFAS; (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's reports on Form 10-K, 10-Q, and 8-K (Reports), as well as compliance risks related to legal or regulatory requirements, government contract requirements, policies and practices, or other matters that require or encourage the Company or its customers, suppliers, vendors, or channel partners to conduct business in a certain way; (6) competitive conditions and customer preferences; (7) the timing and market acceptance of new product and service offerings; (8) the availability and cost of purchased components, compounds, raw materials and energy due to shortages, increased demand and wages, tariffs, supply chain interruptions, or natural or other disasters; (9) unanticipated problems or delays when implementing new business systems and solutions, including with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information or operational technology infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures, and other strategic events resulting from portfolio management actions and other evolving business strategies; (11) operational execution, including the extent to which the Company can realize the benefits of planned productivity improvements, as well as the impact of organizational restructuring activities; (12) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; (13) the Company's credit ratings and its cost of capital; (14) tax-related external conditions, including changes in tax rates, laws or regulations; (15) matters relating to the spin-off of the Company’s Health Care business, including the risk that the expected benefits will not be realized; the risk that the costs or dis-synergies will exceed the anticipated amounts; potential impacts on the Company's relationships with its customers, suppliers, employees, regulators and other counterparties; the ability to realize the desired tax treatment; risks under the agreements and obligations entered into in connection with the spin-off; and (16) matters relating to Combat Arms Earplugs (“CAE”) and related products, including those related to, the August 2023 settlement that is intended to resolve, to the fullest extent possible, all litigation and alleged claims involving the CAE sold or manufactured by the Company’s subsidiary Aearo Technologies and certain of its affiliates (“Aearo Entities”) and/or the Company (“CAE Settlement”). A further description of these factors is located in the Reports under “Cautionary Note Concerning Factors That May Affect Future Results” and “Risk Factors” in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports). Changes in such assumptions or factors could produce significantly different results. The Company assumes no obligation to update any forward-looking statements discussed herein as a result of new information or future events or developments.

◦loss on business divestitures,

Diane Farrow, 612-202-2449

or

Eric Herron, 651-233-0043

3MNews@mmm.com